Mednet Logo
HomeEndocrinologyQuestion

What other considerations for hyperlipidemia management would you have for a patient with multiple prior PCIs whose LDL remains above goal on high intensity statin, ezetimibe, and evolocumab, assuming the patient is compliant with medications?

3
3 Answers
Mednet Member
Mednet Member
Cardiology · Yale School of Medicine

There are a few options, most of which depend on insurance coverage and patient preferences. But first, would do a chart biopsy to assess the efficacy of each of the therapies to better understand the reason for persistent LDL elevation. Perhaps they have a dysfunctional LDL receptor, so upregulatio...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Cardiology · Harvard Medical School

Challenging and agree that compliance is something I would be concerned about. If compliance not the reason patient not at goal, colchicine would be a cheap option to lower risk via an orthogonal pathway of inflammation, particularly if the patient had an elevated hsCRP. Bempedoic acid would be my n...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Cardiology · South Carolina Cardiology Consultants
  1. Don't assume and make sure the patient has had TSH.
  2. Dietary consultation and in-depth analysis.
  3. Emphasize risk factor modification, exercise, weight loss, and consideration of GLP1, if indicated.
  4. Review of medications that could be affecting the lipid profile.

Register or Sign In to see full answer

What other considerations for hyperlipidemia management would you have for a patient with multiple prior PCIs whose LDL remains above goal on high intensity statin, ezetimibe, and evolocumab, assuming the patient is compliant with medications? | Mednet